Home » Posts tagged with » Peter Langmuir
Incyte secures FDA priority review for pemigatinib in cholangiocarcinoma
Delaware-based pharma company Incyte has secured priority review for pemigatinib from the US Food and Drug Administration (FDA) for the treatment of locally advanced or metastatic cholangiocarcinoma. The priority review for pemigatinib is for the treatment of the condition in previously treated patients having FGFR2 fusions or rearrangements. Cholangiocarcinoma is a rare cancer that occurs […]
Business News Today
- JCPenney seeks bankruptcy protection amid Covid-19 disruption
- 7-Eleven rolls out ready-to-bake pizza, tenders, wings, and taquitos
- Eramet to sell TiZir smelting plant in Norway to Tronox for $300m
- AI-based learning platform Quizlet raises $30m in Series C round
- Commonwealth Bank of Australia to sell 55% stake in Colonial First State to KKR
- Kellogg’s launches Kellogg’s JUMBO SNAX to bring cereals in jumbo size packs
- SSR Mining to acquire US gold producer Alacer Gold for $1.72bn
- SBI General Insurance introduces Arogya Sanjeevani Health Insurance Policy
- Latitude 27 Capital acquires jewelry components manufacturer JK Findings
- Core Project phase 1 in North Sea : Subsea 7 wins EPCI contract from IOG
